Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Kezar Life Sciences, Inc. - Common Stock (NQ:KZR)

4.060 -0.050 (-1.22%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Kezar Life Sciences, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) Agenus Inc. (NASDAQ: AGEN)... 
Via Benzinga
Kezar Life Sciences Announces Completion of Enrollment of Its Phase 2 PRESIDIO Clinical Trial of KZR-616 in Polymyositis and Dermatomyositis
From Kezar Life Sciences, Inc.
Via Business Wire
Kezar Life Sciences Reports Second Quarter Financial Results and Provides Business Updates
From Kezar Life Sciences, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For July 20, 2021
Upgrades For Bank of Marin Bancorp (NASDAQ: 
Via Benzinga
Kezar Life Sciences to Participate in the William Blair Biotech Focus Conference 2021
From Kezar Life Sciences, Inc.
Via Business Wire
Kezar Life Sciences Announces Formation of Clinical Advisory Committee
From Kezar Life Sciences, Inc.
Via Business Wire
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Tilray (NASDAQ:TLRY) shares incre... 
Via Benzinga
The Daily Biotech Pulse: FDA Nod For Novartis, iRhythm CEO Quits Abruptly, Moderna Inks Vaccine Supply Agreements
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 1) Anika Therapeutics, Inc. (... 
Via Benzinga
Exposures Product Safety
Kezar Presents Results of the Completed MISSION Phase 1b Study of KZR-616 at EULAR 2021
From Kezar Life Sciences, Inc.
Via Business Wire
Kezar Appoints Rheumatology Industry Expert, Micki Klearman, MD, to its Board of Directors
From Kezar Life Sciences, Inc.
Via Business Wire
Kezar Life Sciences to Participate in the Jefferies Virtual Healthcare Conference
From Kezar Life Sciences, Inc.
Via Business Wire
The Week Ahead In Biotech: ASCO Presentations Front And Center, FDA Decisions Due For Scynexis, Liminal And Alkermes
After having declined through the first half of the week, biotech stocks staged a recovery to close higher in the trading week ended May 28. Broader market sentiment and company-... 
Via Benzinga
Exposures Product Safety
Kezar Life Sciences to Host Virtual MISSION Phase 1b Data Update Call at EULAR 2021 on June 2, 2021
From Kezar Life Sciences, Inc.
Via Business Wire
Kezar Life Sciences Reports First Quarter Financial Results and Provides Business Updates
From Kezar Life Sciences, Inc.
Via Business Wire
Kezar Life Sciences Recognized as 2021 Bay Area Best Places to Work
From Kezar Life Sciences, Inc.
Via Business Wire
Kezar Life Sciences Presents Preclinical Data with IND Candidate KZR-261 at American Association for Cancer Research (AACR) 2021 Virtual Annual Meeting
From Kezar Life Sciences, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.